The BCC immune response consists of mainly T cells; both CD4+ and CD8+ T cells are present in the peritumoral infiltrate in BCC with a CD4+/CD8+ cell ratio of 2:1 (29). The gene discussed is CD8A; the disease is skin basal cell carcinoma.